<code id='07156C6E81'></code><style id='07156C6E81'></style>
    • <acronym id='07156C6E81'></acronym>
      <center id='07156C6E81'><center id='07156C6E81'><tfoot id='07156C6E81'></tfoot></center><abbr id='07156C6E81'><dir id='07156C6E81'><tfoot id='07156C6E81'></tfoot><noframes id='07156C6E81'>

    • <optgroup id='07156C6E81'><strike id='07156C6E81'><sup id='07156C6E81'></sup></strike><code id='07156C6E81'></code></optgroup>
        1. <b id='07156C6E81'><label id='07156C6E81'><select id='07156C6E81'><dt id='07156C6E81'><span id='07156C6E81'></span></dt></select></label></b><u id='07156C6E81'></u>
          <i id='07156C6E81'><strike id='07156C6E81'><tt id='07156C6E81'><pre id='07156C6E81'></pre></tt></strike></i>

          knowledge

          knowledge

          author:comprehensive    Page View:6
          Illustration of a red human heart with an EKG line in the middle. -- health coverage from STAT
          Adobe

          Just weeks after Novo Nordisk announced that its obesity drug Wegovy cut the risk of heart complications in a major trial, the company now has results from a different study showing the treatment can also benefit people with a common type of heart failure.

          The results, published Friday in the New England Journal of Medicine, found that among people with obesity and heart failure with preserved ejection fraction, or HFpEF, those taking Wegovy experienced greater improvements in symptoms and physical function compared with those on placebo. The improvements were greater than what’s been seen in trials of some other HFpEF treatments.

          advertisement

          Novo previously shared topline results in investor calls, but the new study contains the full findings, which are also being presented at the European Society of Cardiology conference this week.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          Wikipedia

          Apple is now the first public company to be valued at $3 trillion
          Apple is now the first public company to be valued at $3 trillion

          6:09FILE-AnApplelogoadornsthefacadeofthedowntownBrooklynApplestoreonMarch14,2020,inNewYork.Applebeca

          read more
          'Investigate these claims': UFO transparency at center of House hearing
          'Investigate these claims': UFO transparency at center of House hearing

          3:47RyanGraves,DavidGrusch,andDavidFravorattendtheHouseOversight&AccountabilityCommittee'sNationalSe

          read more
          After affirmative action ruling, medical educators look to 'holistic review'
          After affirmative action ruling, medical educators look to 'holistic review'

          AnnaMoneymaker/GettyImagesAfterhavingadaytoreadthroughtheSupremeCourt’sdecisiononaffirmativeaction,s

          read more

          Biogen says it will cut costs by $700 million, slash 1,000 jobs

          StevenSenn/APBiogenannouncedanewroundofcostcutsTuesday,sayingthatitplanstosave$700millioninoperating